Fc receptors and the diversity of antibody responses to HIV infection and vaccination.


Journal

Genes and immunity
ISSN: 1476-5470
Titre abrégé: Genes Immun
Pays: England
ID NLM: 100953417

Informations de publication

Date de publication:
08 2022
Historique:
received: 16 02 2022
accepted: 24 05 2022
revised: 19 05 2022
pubmed: 11 6 2022
medline: 23 8 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

The development of an effective vaccine against HIV is desperately needed. The successive failures of HIV vaccine efficacy trials in recent decades have shown the difficulty of inducing an appropriate protective immune response to fight HIV. Different correlates of antibody parameters associated with a decreased risk of HIV-1 acquisition have been identified. However, these parameters are difficult to reproduce and improve, possibly because they have an intricate and combined action. Here, we describe the numerous antibody (Ab) functions associated with HIV-1 protection and report the interrelated parameters regulating their complex functions. Indeed, besides neutralizing and Fc-mediated activity, additional factors such as Ab type, concentration and kinetics of induction, and Fc-receptor expression and binding capacity also influence the protective effect conferred by Abs. As these parameters were described to be associated with ethnicity, age and sex, these additional factors must be considered for the development of an effective immune response. Therefore, future vaccine designs need to consider these multifaceted Ab functions together with the demographic attributes of the patient populations.

Identifiants

pubmed: 35688931
doi: 10.1038/s41435-022-00175-7
pii: 10.1038/s41435-022-00175-7
pmc: PMC9388370
doi:

Substances chimiques

AIDS Vaccines 0
Antibodies, Neutralizing 0
HIV Antibodies 0
Receptors, Fc 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-156

Informations de copyright

© 2022. The Author(s).

Références

Clin Cancer Res. 2019 Feb 1;25(3):989-999
pubmed: 30206165
PLoS One. 2015 Feb 06;10(2):e0117204
pubmed: 25658330
Sci Rep. 2018 Jan 11;8(1):542
pubmed: 29323175
Nature. 2007 Sep 6;449(7158):101-4
pubmed: 17805298
Immunity. 2017 Aug 15;47(2):224-233
pubmed: 28813656
Lancet HIV. 2018 Jul;5(7):e366-e378
pubmed: 29898870
Pediatr Res. 1985 Aug;19(8):846-9
pubmed: 4034287
Proc Natl Acad Sci U S A. 1987 Oct;84(19):6924-8
pubmed: 3477816
Lancet HIV. 2020 Apr;7(4):e238-e248
pubmed: 32035516
AIDS Res Hum Retroviruses. 1999 Jun 10;15(9):847-54
pubmed: 10381173
Front Immunol. 2021 May 04;12:656894
pubmed: 34017334
J Infect Dis. 2017 Apr 15;215(8):1255-1263
pubmed: 28329190
Genes Immun. 2019 Nov;20(8):651-659
pubmed: 30563969
AIDS Rev. 2012 Apr-Jun;14(2):83-100
pubmed: 22627605
JCI Insight. 2020 Jun 18;5(12):
pubmed: 32554928
Immunol Rev. 2015 Nov;268(1):296-310
pubmed: 26497529
J Infect Dis. 2012 Jul 15;206(2):258-66
pubmed: 22561365
Lancet. 1991 Mar 9;337(8741):567-72
pubmed: 1671940
Parasitology. 1997;115 Suppl:S127-40
pubmed: 9571698
J Virol. 2006 Jun;80(12):6177-81
pubmed: 16731957
J Virol. 2011 May;85(10):4828-40
pubmed: 21389135
Lancet Infect Dis. 2014 May;14(5):388-96
pubmed: 24560541
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9019-24
pubmed: 23661056
Front Immunol. 2015 Jul 27;6:368
pubmed: 26284063
Stat Med. 2003 Feb 28;22(4):573-93
pubmed: 12590415
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087938
J Clin Invest. 2019 Nov 1;129(11):4838-4849
pubmed: 31589165
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
Ann Intern Med. 1991 Jan 15;114(2):119-27
pubmed: 1984386
Front Immunol. 2019 Dec 18;10:2968
pubmed: 31921207
Front Immunol. 2017 Nov 20;8:1590
pubmed: 29209323
J Clin Invest. 2014 Sep;124(9):3879-90
pubmed: 25105367
J Infect Dis. 1999 Oct;180(4):1356-60
pubmed: 10479172
Virology. 2011 Jul 5;415(2):160-7
pubmed: 21565376
AIDS. 1991 Feb;5(2):177-80
pubmed: 1903261
J Virol. 2019 Oct 15;93(21):
pubmed: 31434737
J Clin Immunol. 1992 Nov;12(6):429-39
pubmed: 1287035
Hum Mol Genet. 2010 Aug 15;19(16):3282-94
pubmed: 20508037
J Immunol. 2007 May 15;178(10):6596-603
pubmed: 17475891
Curr HIV Res. 2017;15(3):202-215
pubmed: 28322167
Front Immunol. 2021 Dec 15;12:788203
pubmed: 34975881
Elife. 2021 Sep 17;10:
pubmed: 34533134
Immunol Rev. 2017 Jan;275(1):33-48
pubmed: 28133792
N Engl J Med. 2013 Nov 28;369(22):2083-92
pubmed: 24099601
PLoS One. 2012;7(8):e43396
pubmed: 22952672
Sci Transl Med. 2014 Mar 19;6(228):228ra39
pubmed: 24648342
J Immunol. 1995 Jun 1;154(11):6163-73
pubmed: 7751656
Expert Opin Ther Targets. 2021 Jun;25(6):467-477
pubmed: 33754933
JCI Insight. 2020 Nov 5;5(21):
pubmed: 33031099
Mol Syst Biol. 2018 Mar 26;14(3):e7881
pubmed: 29581149
AIDS. 2011 Mar 13;25(5):679-89
pubmed: 21297424
Trends Microbiol. 2015 Apr;23(4):204-11
pubmed: 25572881
J Acquir Immune Defic Syndr (1988). 1992;5(4):325-32
pubmed: 1347787
J Infect Dis. 2005 Mar 1;191(5):654-65
pubmed: 15688278
J Virol. 2015 Jun;89(11):5895-903
pubmed: 25787288
Nature. 2020 Dec;588(7838):485-490
pubmed: 33032297
Front Immunol. 2019 Nov 27;10:2741
pubmed: 31827470
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
Lancet. 2008 Nov 29;372(9653):1881-1893
pubmed: 19012954
Genes Immun. 2016 Mar;17(2):93-104
pubmed: 26673965
J Med Virol. 1994 May;43(1):57-61
pubmed: 8083650
J Virol. 2020 Jan 31;94(4):
pubmed: 31776278
AIDS. 2011 Nov 13;25(17):2089-97
pubmed: 21832938
PLoS One. 2013 Sep 23;8(9):e74855
pubmed: 24086385
Bull World Health Organ. 1975;52(2):179-85
pubmed: 1083305
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
Lancet Infect Dis. 2011 Jul;11(7):507-15
pubmed: 21570355
Cell Rep. 2021 May 25;35(8):109167
pubmed: 34038720
J Infect Dis. 2006 Dec 15;194(12):1661-71
pubmed: 17109337
Viral Immunol. 2003;16(1):69-86
pubmed: 12725690
Int Immunol. 2017 Jul 1;29(7):303-310
pubmed: 28472280
PLoS Med. 2020 Feb 24;17(2):e1003038
pubmed: 32092060
PLoS One. 2011;6(6):e20479
pubmed: 21695251
Med Sci Monit. 2006 Jan;12(1):CR11-16
pubmed: 16369464
Sci Transl Med. 2019 Sep 18;11(510):
pubmed: 31534016
Blood. 2012 Oct 4;120(14):2836-42
pubmed: 22915639
Vaccine. 2013 Aug 2;31(35):3502-18
pubmed: 23707164
J Infect Dis. 1983 Nov;148(5):785-94
pubmed: 6605395
J Virol. 2013 Jul;87(13):7265-81
pubmed: 23576510
Curr HIV/AIDS Rep. 2012 Mar;9(1):64-72
pubmed: 22203469
Nature. 2021 Nov;599(7885):465-470
pubmed: 34547765
Cell. 2015 Apr 9;161(2):387-403
pubmed: 25772697
Curr Opin HIV AIDS. 2019 May;14(3):153-160
pubmed: 30882484
Genes Immun. 2020 Aug;21(4):263-268
pubmed: 32759994
Lancet. 2020 Feb 1;395(10221):384-388
pubmed: 31806257
Cell. 2015 Nov 5;163(4):988-98
pubmed: 26544943
Front Immunol. 2019 Mar 21;10:185
pubmed: 30949161
Front Immunol. 2020 Oct 28;11:590780
pubmed: 33193428
Nat Rev Genet. 2004 Jan;5(1):52-61
pubmed: 14708016
Adv Biol. 2014;2014:
pubmed: 27099867

Auteurs

Li-Yun Lin (LY)

Laboratoire d'ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.

Raphael Carapito (R)

Laboratoire d'ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
Laboratoire d'Immunologie, Plateau Technique de Biologie, Pôle de Biologie, Nouvel Hôpital Civil, Strasbourg, France.

Bin Su (B)

Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Christiane Moog (C)

Laboratoire d'ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France. c.moog@unistra.fr.
Vaccine Research Institute (VRI), Créteil, France. c.moog@unistra.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH